Gripum loses its bid to overturn FDA marketing denial…

US – general: Illinois-based e-liquid manufacturer Gripum’s petition for a review of its marketing denial order (MDO), filed on 8th October 2021 in the Seventh Circuit Court of Appeals, has been denied. The court found that the Food and Drug Administration (FDA)’s denial of the company’s premarket tobacco product application (PMTA) for a range of flavoured liquids was not arbitrary or » Continue Reading.
I'm already a subscriber

Our Key Benefits

The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization